Alessandro Grattoni, Ph.D.
Houston Methodist
Principal Investigator
The DART Resource Program brings together investigators with expertise in nanofluidics, antiretroviral pharmacology, and HIV models at Houston Methodist and collaborating institutions.
Our team spans device engineering, drug delivery, and virology. Together, we develop, refine, and disseminate the NanoDDI implant platform so that investigators can incorporate ultra-long-acting antiretroviral delivery into their preclinical large animal studies.
Houston Methodist
Principal Investigator
Houston Methodist
Multi-PI
Houston Methodist
Pilot Pharmacokinetics Lead
Institution
Pilot Preclinical Study Lead
Houston Methodist
Veterinary Advisor
Houston Methodist
Veterinary Advisor
Houston Methodist
Scientific Veterinary Advisor